Bicycle Therapeutics on a roll

With proof-of-concept data finally in hand for its payload delivery system, Bicycle Therapeutics’ next move is to expand its technology to create new types of bispecifics. 

It’s a milestone 12 years in the making, the first half of which Bicycle Therapeutics plc (NASDAQ:BCYC) spent building its technology platform with minimal funding, before replacing its CEO and getting the data needed to attract funding that could bring it to the clinic...